miR-146b ameliorates LPS-induced acute lung injury [63], whereas its reduction increases IL-17A and promotes T cell acute lymphoblastic leukemia cell migration and invasion [64]. This evidence concerns the gene IL17A and acute lymphoblastic leukemia.